Impact of clonal hematopoiesis in COVID-19 patients at high risk for adverse clinical outcomes

Impact of clonal hematopoiesis in COVID-19 patients at high risk for adverse clinical outcomes

Abstract Purpose Clonal hematopoiesis (CH) describes the aging-associated expansion of mutant hematopoietic cell populations. In various cohorts, CH has been associated with increased morbidity and mortality from non-hematologic diseases such as cardiovascular disease and infections, including COVID...

Full description

Bibliographic Details
Main Authors: Cathy Smith, Bala B. Burugula, Morgan A. Jones, Qing Li, Jacob O. Kitzman, Terrence N. Wong
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Translational Medicine Communications
Subjects:
Clonal hematopoiesis
COVID-19
Chronic kidney disease
Online Access:https://doi.org/10.1186/s41231-023-00155-7

Similar Items

Similar Items